pyridostigmine bromide has been researched along with Lambert-Eaton Myasthenic Syndrome in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barroso, F; Brand, P; Hernández, MA; Köhler, AA; Lautre, A; Marrodán, M; Nogués, M | 1 |
| Kim, SM; Lee, MK; Sunwoo, IN | 1 |
| Chen, F; Chen, J; Ge, R; Jia, R; Zhao, Z; Zheng, Q | 1 |
| Fleury, MC; Tranchant, C | 1 |
| de Kam, ML; den Hartigh, J; Schoemaker, RC; Titulaer, MJ; Tjaden, UR; van Dijk, JG; van Gerven, JM; van Hasselt, JG; Verschuuren, JJ; Wirtz, PW | 1 |
| Keogh, M; Maddison, P; Sedehizadeh, S | 1 |
| Rehman, HU | 1 |
| Connolly, S; Iqbal, M; Langan, Y; Redmond, J | 1 |
| Maddison, P | 1 |
| Newsom-Davis, J | 1 |
| Titulaer, MJ; van Gerven, J; Verschuuren, JJ; Willems, LN; Wirtz, PW | 1 |
| Layzer, RB; Sha, SJ | 1 |
| Kishimoto, R; Matsushima, M; Motomura, M; Nakadate, M; Sasaki, H; Shiraishi, H; Tsuji, S; Yabe, I; Yaguchi, H | 1 |
| Deminière, C; Krim, E; Lagueny, A; Shipley, E | 1 |
| Johansson, S; Lundh, H; Nilsson, O; Rosén, I | 1 |
| Claussen, GC; Head, TC; Kim, DS; Oh, SJ | 1 |
| Massey, JM; Sanders, DB; Tim, RW | 1 |
| Claussen, GC; Kim, DS; Kwon, KH; Mussell, H; Oh, SJ; Tseng, A | 1 |
| Bashuk, RG; Krendel, DA | 1 |
| Schmidt, D | 1 |
6 review(s) available for pyridostigmine bromide and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
[Myasthenia gravis].
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Child; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant, Newborn; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Pyridostigmine Bromide; Radiography, Thoracic; Rituximab; Thymectomy; Thymus Hyperplasia; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Treatment for Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Cholinesterase Inhibitors; Humans; Immunoglobulins, Intravenous; Lambert-Eaton Myasthenic Syndrome; Muscle Strength; Potassium Channel Blockers; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2011 |
Treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Agents; Guanidine; Humans; Immunoglobulins, Intravenous; Lambert-Eaton Myasthenic Syndrome; Placebos; Potassium Channel Blockers; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2012 |
Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Autoantibodies; Autoantigens; Autoimmune Diseases of the Nervous System; Calcium Channels, P-Type; Calcium Channels, Q-Type; Carcinoma, Small Cell; Cholinesterase Inhibitors; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Neoplasm Proteins; Plasmapheresis; Potassium Channel Blockers; Pyridostigmine Bromide | 2004 |
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; Etoposide; Guanidine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Parasympathomimetics; Plasmapheresis; Potassium Channel Blockers; Prednisolone; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2006 |
Ocular myasthenia. Differences between the ocular and the generalized form of myasthenia.
Topics: Adrenal Cortex Hormones; Electrooculography; Humans; Lambert-Eaton Myasthenic Syndrome; Myasthenia Gravis; Oculomotor Muscles; Pyridostigmine Bromide | 1989 |
2 trial(s) available for pyridostigmine bromide and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Lambert-Eaton Myasthenic Syndrome; Middle Aged; Muscle Strength; Pyridostigmine Bromide; Treatment Outcome | 2009 |
Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome.
Topics: Adult; Aged; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophysiology; Female; Guanidine; Guanidines; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Neoplasms; Pyridostigmine Bromide; Time Factors; Treatment Outcome | 1997 |
12 other study(ies) available for pyridostigmine bromide and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
[Lambert-Eaton myasthenic syndrome].
Topics: Adolescent; Adult; Aged; Argentina; Carcinoma, Small Cell; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Neuromuscular Junction; Pyridostigmine Bromide; Retrospective Studies; Symptom Assessment; Young Adult | 2021 |
3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Cholinesterase Inhibitors; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Myasthenia Gravis; Potassium Channel Blockers; Pyridostigmine Bromide | 2018 |
Coexistence of myasthenia gravis and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient: A case report.
Topics: Adrenal Cortex Hormones; Autoantibodies; Cholinesterase Inhibitors; Drug Therapy; Electromyography; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes; Pyridostigmine Bromide; Receptors, Cholinergic; Small Cell Lung Carcinoma; Treatment Outcome | 2018 |
A 90 year old man with difficulty swallowing and proximal muscle weakness.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Deglutition Disorders; Diagnosis, Differential; Fatal Outcome; Glucocorticoids; Hand; Humans; Lambert-Eaton Myasthenic Syndrome; Lower Extremity; Male; Muscle Weakness; Myasthenia Gravis; Prednisolone; Pyridostigmine Bromide | 2012 |
A case of Lambert-Eaton myasthenic syndrome with possible myasthenia gravis.
Topics: Action Potentials; Aged; Cholinesterase Inhibitors; Comorbidity; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Myasthenia Gravis; Pyridostigmine Bromide | 2012 |
Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.
Topics: 4-Aminopyridine; Adolescent; Amifampridine; Cholinesterase Inhibitors; Electrodiagnosis; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Myasthenia Gravis; Potassium Channel Blockers; Pyridostigmine Bromide; Thymectomy | 2007 |
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2007 |
[Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma].
Topics: 4-Aminopyridine; Amifampridine; Carcinoma, Squamous Cell; Cholinesterase Inhibitors; Electrophysiology; Endoscopy; Exercise; Humans; Lambert-Eaton Myasthenic Syndrome; Laryngeal Neoplasms; Male; Middle Aged; Muscular Diseases; Neural Conduction; Potassium Channel Blockers; Pyridostigmine Bromide; Ulnar Nerve; Vocal Cords; Voice Disorders | 2008 |
Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Clinical Protocols; Drug Synergism; Drug Therapy, Combination; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Muscles; Neoplasms; Parasympathomimetics; Pyridostigmine Bromide | 1993 |
Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Amifampridine; Autoantibodies; Carcinoma, Small Cell; Child; Cholinesterase Inhibitors; Electrodiagnosis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Plasmapheresis; Pyridostigmine Bromide; Receptors, Cholinergic | 1998 |
Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Carcinoma, Small Cell; Female; Guanidine; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Parasympathomimetics; Potassium Channel Blockers; Pyridostigmine Bromide; Retrospective Studies; Thyroid Neoplasms | 1998 |
Myasthenia gravis presenting as weakness after magnesium administration.
Topics: Adult; Diagnosis, Differential; Electrophysiology; Female; Humans; Infusions, Parenteral; Lambert-Eaton Myasthenic Syndrome; Magnesium Deficiency; Magnesium Sulfate; Myasthenia Gravis; Paralysis; Pre-Eclampsia; Pregnancy; Pyridostigmine Bromide | 1990 |